Status:
RECRUITING
Individualizing Corticosteroid Use in Pneumonia
Lead Sponsor:
Mayo Clinic
Conditions:
Pneumonia
Eligibility:
All Genders
18+ years
Phase:
PHASE2
Brief Summary
In this study, researchers propose a unique (individualized) approach to steroid treatment seeking to give the right dose of steroid to the right patient and at the right time. This study seeks to com...
Eligibility Criteria
Inclusion
- Hospitalized adult (≥ 18 years) patients.
- Community acquired pneumonia.
Exclusion
- Contraindications or unwillingness to use corticosteroids by patient or provider.
- History of adrenal insufficiency, septic shock, or another absolute indication for steroid use.
- Suspected pulmonary vasculitis or other autoimmune pulmonary disorder.
- Positive pregnancy test
- Comfort care.
Key Trial Info
Start Date :
November 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2027
Estimated Enrollment :
24 Patients enrolled
Trial Details
Trial ID
NCT05334316
Start Date
November 1 2024
End Date
December 1 2027
Last Update
August 3 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Mayo Clinic Rochester
Rochester, Minnesota, United States, 55905